Caplin Point Laboratories Limited (CAPLIPOINT) — Financial Results
Caplin Point Laboratories announced a post-results conference call on May 14, 2026 at 16:30 IST to discuss Q4 and FY2026 financial performance, inviting analysts and institutional investors to review results and business outlook.
About Caplin Point Laboratories Limited (CAPLIPOINT)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when CAPLIPOINT files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CAPLIPOINT — Free💡 Ask AI about this filing
📊 More CAPLIPOINT filings
- Announcement — 11 July 2026 Caplin Point Laboratories announced receipt of a SEBI-mandated confirmation certificate from its reg...
- Financial Results — 27 June 2026 Caplin Point Laboratories announced that its trading window will close on July 1, 2026, to facilitat...
- regulation 31 — 16 June 2026 Caplin Point Laboratories disclosed on April 6, 2026, that no encumbrance on its shares was created ...
- Announcement — 14 May 2026 Caplin Point Laboratories announced that its subsidiary Caplin Steriles received final USFDA approva...
- 🔴 Corporate Action — 14 May 2026 Caplin Point Laboratories announced an interim dividend of INR 4 per share (200% payout) for FY26, w...
🔥 Also filed on 7 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when CAPLIPOINT files new disclosures
Track CAPLIPOINT filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CAPLIPOINT — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research